Cognitive Outcome of Infants with Pompe Disease Receiving Enzyme-Replacement Therapy

J Gordon Millichap

doi:10.15844/pedneurbriefs-26-6-5

Cognitive Outcome of Infants with Pompe Disease Receiving Enzyme-Replacement Therapy

Pediatric Neurology Briefs

Volume 26 (2012): Issue 6

By: J Gordon Millichap

Open Access

|Jun 2012

Abstract

Researchers at University Medical Center, Rotterdam, the Netherlands, and University of Leuven, Belgium prospectively assessed cognitive function in 10 children with classic infantile Pompe disease who had been treated with enzyme-replacement therapy (ERT) since 1999.

References

Ebbink BJ Aarsen FK van Gelder CM van den Hout JM Weisglas-Kuperus N Jaeken J Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy Neurology 2012 May 8 78 19 1512 1518 10.1212/WNL.0b013e3182553c11 22539577
Open DOI Search in Google Scholar Back to article
Chien YH Lee NC Thurberg BL Chiang SC Zhang XK Keutzer J Pompe disease in infants: improving the prognosis by newborn screening and early treatment Pediatrics 2009 Dec 124 6 e1116 1125 10.1542/peds.2008-3667 19948615
Open DOI Search in Google Scholar Back to article
Burton BK Newborn screening for Pompe disease: an update, 2011 Am J Med Genet C Semin Med Genet 2012 Feb 15 160C 1 8 12 10.1002/ajmg.c.31315 22253219
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-26-6-5 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 44 - 44

Published on: Jun 1, 2012

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Severity of Motor Problems,

Speech/Language Delay,

Reliable Assessment of Cognition

© 2012 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 26 (2012): Issue 6